Umbilical cord mesenchymal stem cells labeled with multimodal iron oxide nanoparticles with fluorescent and magnetic properties: Application for in vivo cell tracking

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 337-350

  Sibov, Tatiana T ^a,b   Pavon, Lorena F ^a,b   Miyaki, Liza A ^a   Mamani, Javier B ^a   Nucci, Leopoldo P ^a,b   Alvarim, Larissa T ^a,c   Silveira, Paulo H ^a   Marti, Luciana C ^a   Gamarra, L F ^a,b,c  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Santa Casa de Sao Paulo   (Brazil)

Author keywords

Magnetic resonance imaging; Mesenchymal stem cells; Multimodal iron oxide nanoparticles; Parkinson's disease; Rhodamine

Indexed keywords

MULTIMODAL IRON OXIDE NANOPARTICLE; NANOPARTICLE; RHODAMINE B; UNCLASSIFIED DRUG; FLUORESCENT DYE; MAGNETITE NANOPARTICLE; RHODAMINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL TRACKING; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; CULTURE MEDIUM; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAGNETISM; MALE; MEDIAL FOREBRAIN BUNDLE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; RAT; SUBSTANTIA NIGRA; UMBILICAL CORD BLOOD; ANIMAL; CELL DIFFERENTIATION; CELL MOTION; CHEMISTRY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; FEMALE; FETUS BLOOD; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; NANOMEDICINE; NEURODEGENERATIVE DISEASES; PATHOLOGY; PREGNANCY; PROCEDURES; WISTAR RAT;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL TRACKING; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; FLUORESCENT DYES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NANOMEDICINE; NEURODEGENERATIVE DISEASES; PREGNANCY; RATS; RATS, WISTAR; RHODAMINES; SUBSTANTIA NIGRA;

EID: 84892148207     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S53299     Document Type: Article

References (47)

1. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008;26(3):591-599.
2. Hu SL, Zhang JQ, Hu X, et al. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles. J Cell Biochem. 2009;108(2):529-535.
3. Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vivo surveys. Stem Cells. 2007;25(2):319-331.
4. Yang PL, He XJ, Li HP, et al. [Reactive astrocytes ans nestin expression in adult rats following spinal cord compression injury]. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(10):1752-1755. Chinese.
5. Jomura S, Uy M, Mitchell K, et al. Potential treatment of cerebral global ischemia with Oct-4 umbilical cord matrix cells. Stem Cells. 2007;25(1):98-106.
6. Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells. 2006;24(3): 781-792.
7. Takalo M, Salmien A, Soininen H, et al. Protein aggregation and degradation mechanisms in neurodegenerative diseases. Am J Neurodegener Dis. 2013;2(1):1-14.
8. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003;4(1):49-60.
9. Karussis D, Kassis I, Kurkalli BG, et al. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenative diseases. J Neurol Sci. 2008;265(1-2):131-135.
10. Guzman R, Bliss T, De Los Angeles A, et al. Neural progenitor cells transplanted into the uninjure brain undergo targeted migration after stroke onset. J Neurosci Res. 2007;86(4):873-882.
11. Ren ZH, Wang JY, Zou CL, et al. Labeling of cynomolgus monkey bone marrow-derived mesenchymal stem cells tracking by multimodality imaging. Sci China Life Sci. 2011;54(11):981-987.
12. Deddens LH, Van Tilborg GA, Mulder WJ, et al. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies. Cerebrovasc Dis. 2012;33(4):392-402.
13. Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology. 2003;229(3):838-846.
14. Chang NK, Jeong YY, Park JS, et al. Tracking of neural stem cells in rats with intracerebral hemorrhage by the use of 3T MRI. Korean J Radiol. 2008;9(3):196-204.
15. Liu W, Frank JA. Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol. 2009;70(2):258-264.
16. Lee DE, Koo H, Sun IC, et al. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev. 2012;41(7):2656-2672.
17. Berman SC, Galpoththawela C, Gilad AA, et al. Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med. 2011;65(2):564-574.
18. Albukhaty S, Naderi-Manesh H, Tiraihi T. In vitro labeling of neural stem cells with poly-L-lysine coated super paramagnetic nanoparticles for Green fluorescent protein transfection. Iran Biomed J. 2013;17(2): 71-76.
19. Addicott B, Willman M, Rodriquez J, et al. Mesenchymal stem cell labeling and in vivo MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™. Contrast Media Mol Imaging. 2011;6(1):7-18.
20. Miyaki LA, Sibov TT, Pavon LF, et al. Study of internalization and viability of multimodal nanoparticles for labeling of human umbilical cord mesenchymal stem cells. Einstein (Sao Paulo). 2012;10(2):189-196.
21. Sibov TT, Pavon LF, Oliveira DM, et al. Characterization of adherent umbilical cord blood stromal cells regarding passage, cell number, and nano-biomarking utilization. Cell Reprogram. 2010;12(4):391-403.
22. Sibov TT, Severino P, Marti LC, et al. Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation. Cytotechnology. 2012;64(5):511-521.
23. Mahmoudi M, Simchi A, Imani M, et al. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B Biointerfaces. 2010;75(1):300-309.
24. Jiang J, Chen Y, Zhu Y, et al. Efficient in vitro labeling of human prostate cancer cells with superparamagnetic iron oxide nanoparticles. Cancer Biother Radiopharm. 2011;26(4):461-467.
25. Xia H, Pang RY, Zhang R, et al. Study of colloidal particle Brownian aggregation by low-coherence fiber optic dynamic light scattering. J Colloid Interface Sci. 2012;376(1):322-326.
26. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004;17(7):484-499.
27. Frank JA, Zywicke H, Jordan EK, et al. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol. 2002;Suppl 2:S484-S487.
28. Billotey C, Wilhem C, Devaud M, et al. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn Reson Med. 2003;49(4):646-654.
29. Gomes MZ, Del-Bel EA. Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase. Brain Res Bull. 2003;62(2):107-115.
30. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. New York, NY, USA: Academic Press; 1998.
31. Gamarra LF, Pontuschka WM, Amaro E Jr, et al. Kinetics of elimination and distribution in blood and liver of biocompatible ferrofluids based on Fe3O4 nanoparticles: An EPR and XRF study. Mater Sci Eng C Mater Biol Appl. 2008;28(4):519-525.
32. Lee JW, Fang X, Krasnodembskaya A, et al. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells. 2011;29(6):913-919.
33. Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev. 2011; 7(1):195-207.
34. Li XX, Li KA, Qin JB, et al. In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia. Int J Nanomedicine. 2013;8:1063-1073.
35. Petri-Fink A, Steitz B, Finka A, et al. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm. 2008;68(1):129-137.
36. Vonarbourg A, Passirani C, Saulnier P, et al. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials. 2006; 27(24):4356-4373.
37. Galuppo LD, Kamau SW, Steitz B, et al. Gene expression in synovial membrane cells after intraarticular delivery of plasmid-linked superparamagnetic iron oxide particles - a preliminary study in sheep. J Nanosci Nanotechnol. 2006;6(9-10):2841-2852.
38. Myers D. Surfaces, Interfaces, and Colloids: Principles and Applications. New York, NY, USA: VCH Publishers; 1991.
39. Shan L. Multimodal, Rhodamine B isothiocyanate-incorporated, silica coated magnetic nanoparticle-labeled human cord blood-derived mesenchymal stem cells for cell tracking. Molecular Imaging and Contrast Agent Database. Bethesda, MD, USA: National Center for Biotechnology Information; 2009.
40. Nel AE, Mädler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-biointerface. Nat Mater. 2009;8(7): 543-557.
41. Decuzzi P, Ferrari M. The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials. 2007;28(18):2915-2922.
42. Howes MT, Kirkham M, Riches J, et al. Clathrin-independent carriers form a high capacity endocytic sorting at the leading edge of migrating cells. J Cell Biol. 2010;190(4):675-691.
43. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857-902.
44. Gillingham AK, Munro S. The small G proteins of the Arf family and their regulators. Annu Rev Cell Dev Biol. 2007;23:579-611.
45. Girao H, Geli MI, Idrissi FZ. Actin in the endocytic pathway: from yeast to mammals. FEBS Lett. 2008;582(14):2112-2119.
46. Gratton SE, Ropp PA, Pohlhaus PD, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A. 2008;105(33):11613-11618.
47. Pawelczyk E, Arbab AS, Chaudhry A, et al. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells. 2008;26(5):1366-1375.